TRENTON, N.J.—The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth.
The agency on March 19 approved Sage Therapeutics’ Zulresso, an IV drug given over 2 ½ days.
FDA Approves Drug for Treating Postpartum Depression
Save
FDA has approved a drug for postpartum depression. Pixabay
Updated:
